JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 3 Delay in clinical worsening in bosentan-treated patients. Clinical worsening was defined as death, premature withdrawal from study, hospitalization for worsening pulmonary arterial hypertension, or initiation of epoprostenol. (From Rubin et al. [28]).





Right arrow Return to article

HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK